Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;594(10):1467-1476.
doi: 10.1002/1873-3468.13759. Epub 2020 Mar 11.

Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1

Mark J Demma  1 , Michael J Hohn  2 , Angie Sun  3 , Claudio Mapelli  4 , Brian Hall  3 , Abbas Walji  4 , Jennifer O'Neil  1
Affiliations
Free article

Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1

Mark J Demma et al. FEBS Lett. 2020 May.
Free article

Abstract

Myc, a transcription factor with oncogenic activity, is upregulated by amplification, translocation, and mutation of the cellular pathways that regulate its stability. Inhibition of the Myc oncogene by various modalities has had limited success. One Myc inhibitor, Omomyc, has limited cellular and in vivo activity. Here, we report a mini-protein, referred to as Mad, which is derived from the cellular Myc antagonist Mxd1. Mad localizes to the nucleus in cells and is 10-fold more potent than Omomyc in inhibiting Myc-driven cell proliferation. Similar to Mxd1, Mad also interacts with Max, the binding partner of Myc, and with the nucleolar upstream binding factor. Mad binds to E-Box DNA in the promoters of Myc target genes and represses Myc-mediated transcription to a greater extent than Omomyc. Overall, Mad appears to be more potent than Omomyc both in vitro and in cells.

Keywords: Max; Myc; Myc inhibitors; Omomyc; cancer; oncogene.

PubMed Disclaimer

References

    1. Meyer N and Penn LZ (2008) Reflecting on 25 years of Myc. Nat Rev Cancer 8, 976-990.
    1. Wasylishen AR and Penn LZ (2010) Myc: the beauty and the beast. Genes Cancer 1, 532-541.
    1. Dang CV (2012) MYC on the path to cancer. Cell 149, 22-35.
    1. Kato GJ, Barret J, Villa-Garcia M and Dang CV (1990) An amino terminal c-Myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10, 5914-5920.
    1. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H (1990) Sequence specific DNA binding by c-Myc protein. Science 250, 1149-1151.

MeSH terms

Substances

LinkOut - more resources